Anzeige
Mehr »
Login
Freitag, 01.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Neuer Gold Rekord bei knapp 2.800 USD und Übernahme-Zirkus!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
411 Leser
Artikel bewerten:
(1)

Solon Management Consulting and Altman Vilandrie & Company Merge to Form Altman Solon

Merger creates the largest global strategy consulting firm focused exclusively on the Telecoms, Media and Technology (TMT) sectors

WARSAW, Poland, July 8, 2020 /PRNewswire/ -- Leading strategy consulting groups Altman Vilandrie & Company and Solon Management Consulting have announced their merger to form Altman Solon, the world's largest strategy consulting firm focused exclusively on the Telecommunications, Media and Technology (TMT) sectors. The news solidifies a decade-long partnership between the two firms to increase their global footprint and apply their experience and skills to TMT market leaders, challenger brands and investors around the world.

Altman Solon Logo (PRNewsfoto/Altman Solon)

Altman Solon's team of sector specialists brings together deep market expertise with a shared passion and intellectual curiosity to solve challenging strategy problems and create real-world solutions for TMT players. Altman Solon helps clients identify, develop and implement company strategies, new market entry approaches, digital innovation and global M&A. It helps its investor clients understand markets, conduct due diligence, and make high-stakes investment decisions with confidence.

Prior to the merger, Altman Vilandrie & Company and Solon Management Consulting were sector leaders in their respective markets: Altman Vilandrie & Company focused on the Americas and Solon Management Consulting on Europe and Africa. The teams have shaped strategy and implemented many of the era-defining developments in the TMT sector including deployment of fiber and 5G networks, helping global media companies adapt to the disruption of OTT and streaming services, advising major technology firms on strategies to enter the burgeoning SaaS and cloud computing market, and evaluating deals and creating TMT opportunities for major private equity and infrastructure investors around the globe. By merging, the two businesses bring together their extensive portfolio to make Altman Solon the largest global strategy consulting firm dedicated to the TMT sector, with projects completed in over 100 countries and around 300 employees across offices in Boston, London, Milan, Munich, New York, Paris, San Francisco and Warsaw.

Rory J. Altman and Patrick Bellenbaum will assume joint roles of Managing Partners at Altman Solon. The merged firm is comprised of all partners from the previous firms.

Rory J. Altman, who founded Altman Vilandrie & Company in 2002 and is Managing Partner at Altman Solon, comments: "We have always strived to give our clients in the telecommunications, media and technology sectors a competitive edge by offering deep sector knowledge from TMT strategy specialists. The merger of our two strongly growing businesses takes this to the next level, by giving Altman Solon the seamless capability to solve global TMT problems with expertise drawn from a much broader pool of markets, situations and clients, combined with the deepest pool of dedicated TMT talent that only we can offer."

Patrick Bellenbaum, Partner and Managing Director at Solon Management Consulting, and Managing Partner at Altman Solon, comments: "We had and always will have a natural thirst to stay at the cutting edge of the TMT industries. Today, even more than before, our clients can benefit from understanding worldwide best practices, business scenarios and technical developments. The merger of our two great firms ensures exactly this. It makes Altman Solon the only strategy consulting firm offering TMT sector specific advice across Europe, the Americas as well as Africa and Asia. I am proud of our team and what it has achieved, and I am excited to bring our specialized consultants from around the world together to deliver the most comprehensive consulting services in TMT."

About Altman Solon:

Altman Solon is a global strategy consulting firm that works across the telecommunications, media and technology (TMT) sectors. Our consultants are united by passion and intellectual curiosity for TMT and work with market leaders, challenger brands and investors in these industries.

Our collaborative team structure brings together industry experts and data analysts to apply their experience and skills to create real-world solutions for global TMT players. We support our corporate clients in identifying, developing and implementing company strategies, new market entry approaches, digital innovation and global M&A. We help our investor clients understand markets, conduct due diligence and make high-stakes decisions with confidence.

Altman Solon is formed following a merger between Altman Vilandrie & Company and Solon Management Consulting in 2020, cementing a decade-long partnership across the Atlantic to form the world's largest global strategy consulting firm with an exclusive focus on the TMT sectors.

Altman Solon has extensive international reach with around 300 employees based in Boston, London, Milan, Munich, New York, Paris, San Francisco and Warsaw, with successful projects completed across more than 100 countries.

For further information, please visit www.altmansolon.com.

Logo - https://mma.prnewswire.com/media/1200170/Altman_Solon_Logo.jpg

Media contact: To arrange an interview or for further information, please contact altmansolon@diffusionpr.com

© 2020 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.